SARS-CoV-2感染及感染严重程度对2型糖尿病患者较长期血糖控制和体重的影响
该回顾性队列研究利用美国国家COVID队列协作组(N3C)的纵向电子健康记录数据,评估SARS-CoV-2感染及感染严重程度与2型糖尿病(T2D)患者较长期血糖控制和体重的关联。研究发现,感染SARS-CoV-2的患者与对照组在指数日期后平均HbA1c或体重无显著差异;机械通气与COVID-19后平均HbA1c下降相关。
要点
- 在T2D患者中,SARS-CoV-2感染与对照组相比,指数日期后1年内平均HbA1c和体重无显著差异。
- 机械通气与COVID-19后平均HbA1c下降相关。
- 研究采用倾向评分匹配以平衡人口学特征、合并症和降糖药物使用。
核心结论
- 在美国多中心T2D患者队列中,COVID-19患者较长期平均HbA1c或体重无显著变化。
- 机械通气与COVID-19后HbA1c下降相关。
研究设计与样本
- 回顾性队列研究,使用美国国家COVID队列协作组(N3C)的纵向电子健康记录数据。
- 纳入年龄≥18岁、ICD-10诊断为T2D、且在首次COVID-19诊断或SARS-CoV-2阴性检测指数日期前后至少各有一次HbA1c和体重测量的患者。
- 采用倾向评分识别在人口学特征、合并症和降糖药物使用方面平衡的匹配队列。
主要发现
- 感染SARS-CoV-2的患者与对照组在指数日期后90天开始1年期间的平均HbA1c和平均体重无显著差异。
- 机械通气与COVID-19后平均HbA1c下降相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the association of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severity of infection with longer-term glycemic control and weight in people with type 2 diabetes (T2D) in the U.S. RESEARCH DESIGN AND METHODS: We conducted a retrospective cohort study using longitudinal electronic health record data of patients with SARS-CoV-2 infection from the National COVID Cohort Collaborative (N3C). Patients were ≥18 years old with an ICD-10 diagnosis of T2D and at least one HbA1c and weight measurement prior to and after an index date of their first coronavirus disease 2019 (COVID-19) diagnosis or negative SARS-CoV-2 test. We used propensity scores to identify a matched cohort balanced on demographic characteristics, comorbidities, and medications used to treat diabetes. The primary outcome was the postindex average HbA1c and postindex average weight over a 1 year time period beginning 90 days after the index date among patients who did and did not have SARS-CoV-2 infection. Secondary outcomes were postindex average HbA1c and weight in patients who required hospitalization or mechanical ventilation. RESULTS: There was no significant difference in the postindex average HbA1c or weight in patients who had SARS-CoV-2 infection compared with control subjects. Mechanical ventilation was associated with a decrease in average HbA1c after COVID-19. CONCLUSIONS: In a multicenter cohort of patients in the U.S. with preexisting T2D, there was no significant change in longer-term average HbA1c or weight among patients who had COVID-19. Mechanical ventilation was associated with a decrease in HbA1c after COVID-19.
引用
- Wong R, Vaddavalli R, Hall MA, et al. Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes. Diabetes Care. 2022. PMID: 36098660. doi:10.2337/dc22-0730
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。